Recently the autoantibody against the S100A7 protein has been found to be elevated in early and late-stage ovarian cancer but the clinical usefulness has yet to be investigated
Recently theautoantibody against the S100A7 protein has beenfound to be elevated in early and late-stage ovariancancer but the clinical usefulness has yet to beinvestigated